首页> 美国政府科技报告 >Non-Invasive Markers of Tumor Growth, Metastases, and Sensitivity to Anti- Neoplastic Therapy; Annual rept. 6 Dec 2006-5 Dec 2008
【24h】

Non-Invasive Markers of Tumor Growth, Metastases, and Sensitivity to Anti- Neoplastic Therapy; Annual rept. 6 Dec 2006-5 Dec 2008

机译:肿瘤生长,转移和抗肿瘤治疗敏感性的非侵入性标记物;年度报告。 2006年12月6日至2008年12月6日

获取原文

摘要

The goals of this application are to develop methods to non- invasively differentiate fast and slow growing prostate tumors and also develop methods to evaluate response to anti-angiogenic agents. Validation of the results will be based on tumor growth metastases and microvessel density measurement (antiangiogenic studies). To date we have succeeded in demonstrating that the R3327AT rat prostate tumor which is relatively radiation resistant has detectable lactate which is heterogeneously distributed once the tumor exceeds 6OOmm3. In contrast the radiation sensitive slow growing Dunning H does not have lactate that is detectable by NMR. DCE-MRI studies do not suggest differences between slow and fast growing rat prostate tumors.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号